Keensight Capital’s Symeres adds on Exemplify
Keensight Capital-backed Symeres has acquired Exemplify BioPharma, a US-based provider of Chemistry, Manufacturing and Controls (CMC) services for drug development.
Keensight Capital-backed Symeres has acquired Exemplify BioPharma, a US-based provider of Chemistry, Manufacturing and Controls (CMC) services for drug development.